Developed from ISHLT2020 Session 29 (ORAL)
 

Moderators:

Ulrich Jorde, MD, Montefiore Medical Center / Albert Einstein College of Medicine, Bronx, NY, USA Sebastian V. Rojas, MD, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany

Welcome & Recognition of ISHLT/OH Frazier Award in MCS Translational Research, sponsored by Medtronic
Joseph Rogers, MD, Duke University Medical Center, Durham, NC, USA
Jordan R.H. Hoffman, MD, Assistant Professor in Cardiac Surgery at Vanderbilt University School of Medicine in Nashville, TN., receives the O.H. Frazier Award in MCS Translational Research sponsored by Medtronic. The $65,000 award will allow Dr. Hoffman to study complications that arise in some heart failure patients who rely on Left Ventricular Assist Devices (LVADs) for cardiac support.

Welcome and Program Panel Introduction
Moderator Sebastian Rojas, MD

(93) The Impact of Aspirin Dose on Hemocompatibility-Related Adverse Events during HeartMate 3 Support - An Analysis from the MOMENTUM 3 Trial
Omar Saeed, MD, Montefiore Medical Center, Bronx, NY, USA

(94) Discontinuation of Aspirin in HeartMate 3: Long-Term Outcomes
Sern Lim, MD, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom

(96) Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients without Antiplatelet Therapy
Ulrich Jorde, MD, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA

(97) Early Bleeding is Associated with Increased Length of Stay and Early Death in LVAD Recipients
Valluvan Jeevanandam, MD, University of Chicago, Chicago, IL, USA

(98) Impact of Hemocompatibility on Emergency Resource Utilization in Ventricular Assist Device Patients
Jonathan J. Edwards, MD, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

(99) Mechanical Circulatory Support (MCS) Patients Bridged with Enoxaparin in the Outpatient Setting: Cedars-Sinai Medical Center Experience
Lawrence S. Czer, MD, Cedars Sinai Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA

Live Q & A Segment with All Presenters
Led by Moderator Ulrich Jorde, MD

ISHLT MCS Interdisciplinary Network Update
Diyar Saeed, MD, PhD, Leipzig Heart Center, Leipzig, Germany
Chair, MCS Interdisciplinary Network Steering Committee

ISHLT Announcements
Greg Schultz, CEO, ISHLT, Addison, TX, USA
 

Continuing Education Information

Learning Objectives – At the conclusion of this webinar attendees will increase the knowledge, performance and/or practice by listening to seven (7) abstracts that were to be presented at the 2020 ISHLT Scientific Annual Meeting. The presenters will be disseminating data as it relates to Anticoagulation and Bleeding Complications in MCS Patients. Abstract presentations have been peer reviewed.

Target Audience – The target audience for the December webinar session includes physicians, surgeons, scientists, pharmacists, nurses, transplant coordinators and other allied health and social science professionals engaged in the management and treatment of patients with advanced heart or lung disease, basic science or clinical research related to these fields, or other specialties which cause them to become involved in the treatment of patients with advanced heart or lung disease.

Activity Designed to Change – This activity is designed to change knowledge, competence and performance.

Learning Attributes   Patient Care and Medical Knowledge

Disclosures – Current guidelines state that participants in continuing medical and allied health professional education activities must be made aware of any affiliation or financial interest that may affect the program content or a speaker’s presentation. Planners, Faculty and Chairs participating in this meeting are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation or service as Chair/Planner. Disclosures will be distributed in the Learner Notification that you receive as a participant prior to the live virtual session. Additionally, all speakers have been asked to verbally disclose at the start of their presentation any financial interest or affiliations and to indicate if a product they are discussing is not labeled for the use under discussion or is still investigational.

Disclaimer – The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the ISHLT.

Documenting CME Credits – The ISHLT provides CME certificates to those who have participated in an ISHLT educational activity. The ISHLT does not submit credits to regulating bodies or certifying organizations on behalf of the participants. It is the participants responsibility to submit proof of credits on his or her own behalf.